The distinction between normal aging and a medical condition requiring intervention is not always clear, particularly when it comes to testosterone levels in men over 50. Testosterone declines gradually in all men as they age. This is an established physiological fact. However, when this decline causes symptoms that significantly affect quality of life, the conversation shifts from accepting the inevitable to considering whether treatment might restore function and wellbeing.
At Ageless Center, our men’s hormone therapy programs in Kentucky help men understand whether their symptoms warrant medical intervention or represent changes that can be addressed through lifestyle modifications alone. This article examines the clinical evidence surrounding testosterone therapy for men over 50, exploring when treatment is appropriate, what benefits have been demonstrated in research, and what considerations should guide the decision to pursue therapy.
RESEARCH SNAPSHOT: The European Male Ageing Study (EMAS)
The European Male Ageing Study, published in the New England Journal of Medicine, represents one of the most comprehensive investigations of testosterone decline in aging men. This population-based study of 3,369 men aged 40 to 79 years found that the prevalence of late-onset hypogonadism (low testosterone with symptoms) increased significantly with age:
- Ages 40-49: 0.1% prevalence
- Ages 50-59: 0.6% prevalence
- Ages 60-69: 3.2% prevalence
- Ages 70-79: 5.1% prevalence
The study established that symptomatic testosterone deficiency requires both biochemical evidence (low serum testosterone) and clinical symptoms, particularly sexual symptoms, to constitute a diagnosable condition.
Source: Wu FC, et al. Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men. N Engl J Med. 2010;363:123-135.
Understanding the Biology of Testosterone Decline
Testosterone production follows a predictable pattern across the male lifespan. Levels peak during late adolescence and early adulthood, typically reaching maximum concentrations between ages 19 and 30. After age 30, testosterone levels decline at an estimated rate of 1% to 3% per year. By age 60, approximately 20% of men have testosterone levels below the normal range established for younger men. By age 80, this figure approaches 50%.
This decline occurs through several mechanisms. The Leydig cells in the testes, responsible for testosterone production, decrease in number and function with age. The hypothalamic-pituitary axis, which regulates testosterone production through hormonal signals, becomes less responsive. Additionally, sex hormone-binding globulin (SHBG) increases with age, binding more testosterone and reducing the amount available for biological activity.
The fraction of testosterone that matters clinically is the bioavailable portion, which includes free testosterone and testosterone loosely bound to albumin. Because SHBG increases with age while total testosterone decreases, the decline in bioavailable testosterone is actually steeper than the decline in total testosterone.
KEY STATISTIC: Prevalence by the Numbers
Research from the Baltimore Longitudinal Study of Aging and the Massachusetts Male Aging Study has documented the scope of testosterone decline:
- 1-3% annual decline in testosterone after age 30
- 20% of men in their 60s have testosterone below normal range
- 30% of men in their 70s have testosterone below normal range
- 50% of men in their 80s have testosterone below normal range
- 40% of men over 45 meet biochemical criteria for hypogonadism
However, symptomatic hypogonadism (low testosterone plus clinical symptoms) affects a smaller proportion, estimated at approximately 2-6% of men over 50.
Recognizing Symptoms That Warrant Evaluation
Not every man with declining testosterone experiences bothersome symptoms. Many men maintain adequate testosterone levels for their physiological needs well into advanced age. Others experience significant symptoms even with testosterone levels that technically fall within normal ranges. The clinical picture matters as much as the laboratory values.
Sexual symptoms show the strongest correlation with low testosterone levels. These include reduced libido (decreased interest in sexual activity), erectile dysfunction that does not respond adequately to medications like sildenafil, and reduced frequency of morning erections. The European Male Ageing Study found that the presence of three sexual symptoms, combined with testosterone below 11 nmol/L (approximately 317 ng/dL), most accurately identified men with clinically significant testosterone deficiency.
Physical symptoms associated with low testosterone include:
- Decreased muscle mass and strength, often noticed as difficulty performing physical tasks that were previously manageable
- Increased body fat, particularly visceral fat around the midsection
- Reduced bone density, which may not cause symptoms until a fracture occurs
- Decreased energy and increased fatigue that persists despite adequate sleep
- Hot flashes, though less common than in women experiencing menopause
Psychological and cognitive symptoms can include depressed mood, irritability, difficulty concentrating, and reduced motivation. These symptoms overlap significantly with depression and other conditions, making isolated psychological symptoms less specific for testosterone deficiency.
The Diagnostic Process
Current guidelines recommend measuring testosterone levels in the morning, when they are typically highest, on at least two separate occasions before establishing a diagnosis.
Diagnostic Component | Recommendation | Purpose |
Symptom assessment | Detailed history focusing on sexual, physical, and psychological symptoms | Establishes clinical indication for testing |
Total testosterone | Morning measurement, fasting preferred | Primary screening test |
Repeat total testosterone | Second morning measurement if first is low | Confirms persistent deficiency |
Free testosterone or bioavailable testosterone | Calculate or measure directly | Accounts for SHBG variations |
LH and FSH | Measure if testosterone is confirmed low | Distinguishes primary from secondary hypogonadism |
Prolactin | Measure if testosterone is very low or secondary hypogonadism suspected | Rules out pituitary tumor |
Complete blood count | Baseline before treatment | Monitors for polycythemia |
PSA | Baseline before treatment in men over 40 | Prostate health screening |
The threshold for diagnosing low testosterone has been debated. Most laboratories use 300 ng/dL as the lower limit of normal, though some experts argue this cutoff is too low for older men. The Endocrine Society guidelines suggest that men with total testosterone below 300 ng/dL on two measurements, combined with symptoms, are candidates for treatment consideration.
It is equally important to identify reversible causes of low testosterone before initiating therapy. Obesity, poorly controlled diabetes, sleep apnea, chronic opioid use, and certain medications can all suppress testosterone production. Addressing these underlying factors may restore testosterone levels without requiring replacement therapy.
Who Is a Candidate for Testosterone Therapy
Appropriate candidacy for testosterone therapy requires meeting both biochemical and clinical criteria. The presence of symptoms matters. Treating a laboratory value in the absence of symptoms is not supported by current evidence.
Men who are generally considered appropriate candidates include those with:
- Confirmed low testosterone on two morning measurements (typically below 300 ng/dL)
- Clinical symptoms consistent with testosterone deficiency, particularly sexual symptoms
- No contraindications to therapy
- Understanding of the potential benefits and risks
- Willingness to commit to ongoing monitoring
Contraindications to testosterone therapy include active prostate cancer, breast cancer, uncontrolled heart failure, untreated severe sleep apnea, desire for fertility (testosterone suppresses sperm production), and hematocrit above 50% (indicating existing polycythemia).
Men with certain conditions require careful evaluation and discussion before considering therapy. These include men with a history of prostate cancer (though recent evidence suggests therapy may be safe in select cases after curative treatment), cardiovascular disease, and blood clotting disorders.
CLINICAL EVIDENCE: Benefits Demonstrated in Research
Sexual Function: Significant improvement in sexual desire, erectile function, and overall sexual activity compared to placebo.
Physical Function: Modest improvements in 6-minute walking distance and self-reported walking ability. Improved muscle strength when combined with resistance exercise.
Mood and Vitality: Modest but clinically meaningful improvements in energy, mood, and depressive symptoms in men without major depressive disorder.
Bone Density: Increased bone mineral density and estimated bone strength at the spine and hip.
Body Composition: Increased lean body mass and decreased fat mass.
Anemia: Correction of unexplained anemia in a significant proportion of men with low-normal hemoglobin.
The Treatment Process at Ageless Center
Testosterone therapy requires individualized treatment planning and ongoing medical supervision. At Ageless Center, the process begins with comprehensive evaluation.
The initial consultation includes detailed symptom assessment, review of medical history, physical examination, and laboratory testing. We evaluate not only testosterone levels but also factors that might be contributing to symptoms or affecting treatment safety.
If treatment is appropriate, we discuss the available delivery methods and help each patient choose the option that best fits their lifestyle and preferences. Bioidentical testosterone formulations, which are structurally identical to the testosterone naturally produced by the body, offer effective treatment with potentially fewer side effects than synthetic alternatives.
Delivery methods include:
- Injectable testosterone: Administered every one to two weeks, offering consistent levels with proper dosing
- Transdermal gels: Applied daily to the skin, providing steady testosterone delivery
- Testosterone pellets: Implanted under the skin every three to six months, offering convenience and stable levels
Each method has advantages and considerations. Injectable testosterone provides reliable absorption but requires regular injections. Gels offer flexibility and steady levels but require daily application and care to prevent transfer to others. Pellets eliminate the need for daily or weekly administration but require a minor procedure for insertion.
Following treatment initiation, regular monitoring ensures safety and efficacy. We check testosterone levels to confirm they have reached the target range, typically the mid-normal range for healthy young men. We also monitor hematocrit (red blood cell concentration), which can increase with testosterone therapy, and PSA levels for prostate health screening.
Our 90-day timeline for HRT results provides detailed information about what to expect during the initial months of treatment.
Expected Benefits and Realistic Timelines
Understanding when improvements occur helps set appropriate expectations. Different symptoms respond on different timelines.
Sexual function improvements typically appear within the first three to six weeks, with continued improvement over three to six months. Libido often improves before erectile function, and men using phosphodiesterase-5 inhibitors (like Viagra or Cialis) may find these medications work more effectively once testosterone levels are optimized.
Energy and mood improvements often begin within the first few weeks, though full benefits may take two to three months to manifest. Men frequently report feeling “more like themselves” as testosterone reaches therapeutic levels.
Body composition changes require longer timeframes. Increases in lean muscle mass and decreases in fat mass typically become measurable after three to six months, with continued improvement over the first year. These changes are enhanced by resistance exercise and adequate protein intake.
Bone density improvements take the longest to achieve. Measurable increases in bone mineral density typically require one to two years of consistent therapy. However, the treatment may begin strengthening bone architecture earlier than density measurements reflect.
MONITORING REQUIREMENTS: Ongoing Safety Assessment
Testosterone therapy requires regular monitoring to ensure safety and optimize results.
Standard monitoring includes:
First 3-6 months:
- Testosterone levels at 1-3 months to confirm therapeutic range
- Hematocrit at 3-6 months (elevated levels may require dose adjustment or phlebotomy)
- Symptom reassessment to evaluate treatment response
Ongoing (annually):
- Testosterone levels to confirm stable absorption
- Complete blood count including hematocrit
- PSA for prostate screening in appropriate candidates
- Metabolic panel as clinically indicated
- Symptom and quality of life assessment
Safety Considerations and Risk Management
Contemporary evidence has clarified many historical concerns about testosterone therapy, though vigilance remains appropriate.
Cardiovascular safety was a significant concern following early retrospective studies suggesting increased risk. However, the TRAVERSE trial, a large randomized controlled trial specifically designed to assess cardiovascular safety, found no significant increase in major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) in men treated with testosterone compared to placebo. Current evidence supports that testosterone therapy, when properly administered and monitored in appropriate candidates, does not increase cardiovascular risk.
Prostate health concerns have similarly evolved. Testosterone does not cause prostate cancer. Large studies have found no increase in prostate cancer incidence among men receiving testosterone therapy. However, because testosterone can stimulate growth of existing prostate cancer, screening with PSA and digital rectal examination before initiating therapy, and ongoing monitoring during treatment, remains standard practice.
Polycythemia (elevated red blood cell count) is the most common adverse effect requiring management. Testosterone stimulates erythropoiesis, which is beneficial for men with anemia but can raise hematocrit to levels that increase blood viscosity and clotting risk. Monitoring hematocrit and adjusting dosing or performing therapeutic phlebotomy when levels exceed 54% manages this risk effectively.
Other potential effects include acne (usually mild), breast tenderness or enlargement (managed with dose adjustment or additional medications), testicular atrophy (expected when exogenous testosterone suppresses the body’s production), and fertility suppression (testosterone dramatically reduces sperm production and should not be used by men trying to conceive).
Integrating Testosterone Therapy with Comprehensive Care
Hormone optimization works best as part of a broader health strategy. At Ageless Center, we integrate testosterone therapy with guidance on nutrition, exercise, sleep, and stress management.
Resistance training enhances the anabolic effects of testosterone on muscle. Studies show that the combination of testosterone therapy and resistance exercise produces greater improvements in muscle mass and strength than either intervention alone. We encourage patients to incorporate strength training two to three times weekly.
Nutrition supports hormone health through adequate protein intake (essential for muscle synthesis), healthy fats (required for hormone production), and weight management (obesity suppresses testosterone). Our weight loss programs in Lexington, Louisville, & London can help men whose excess weight may be contributing to low testosterone.
Sleep quality directly affects testosterone production. Most testosterone is produced during sleep, and sleep disorders like obstructive sleep apnea both suppress testosterone and may be worsened by obesity. Addressing sleep issues improves hormone profiles and overall health.
Frequently Asked Questions
At what testosterone level should I consider treatment?
Most guidelines suggest that men with total testosterone consistently below 300 ng/dL, combined with symptoms of deficiency, are candidates for treatment consideration. However, symptoms matter as much as numbers. Some men experience significant symptoms with levels in the low-normal range (300-400 ng/dL), while others remain asymptomatic with levels below 300.
Will testosterone therapy affect my prostate?
Current evidence shows that testosterone therapy does not cause prostate cancer. However, testosterone can stimulate growth of existing prostate cancer, which is why screening before treatment and ongoing monitoring are essential. Men with a history of prostate cancer should discuss their specific situation with both their urologist and hormone specialist.
How long do I need to stay on testosterone therapy?
For most men with age-related testosterone deficiency, therapy is typically long-term. If you stop testosterone therapy, your levels will eventually return to their pre-treatment state (or potentially lower initially while your body recovers its production capacity), and symptoms will likely recur. Some men use therapy indefinitely; others use it for defined periods based on changing circumstances.
Will my body stop making testosterone if I take it externally?
Yes. Exogenous testosterone suppresses the hypothalamic-pituitary-testicular axis, reducing your body’s natural testosterone production. This also suppresses sperm production, which is why testosterone therapy is not appropriate for men actively trying to conceive. If therapy is discontinued, natural production typically recovers over several months, though recovery may be incomplete in some cases.
Can I use testosterone therapy if I have heart disease?
The TRAVERSE trial found no increase in cardiovascular events with testosterone therapy in men with or at high risk for cardiovascular disease. Current guidelines do not list stable cardiovascular disease as a contraindication. However, men with uncontrolled heart failure should not receive testosterone therapy, and those with recent cardiovascular events should discuss timing with their cardiologist.
What if testosterone therapy does not help my symptoms?
If symptoms persist despite achieving therapeutic testosterone levels, this suggests other contributing factors. Depression, sleep disorders, thyroid dysfunction, and other medical conditions can cause overlapping symptoms. A thorough evaluation to identify and address these factors may be necessary.
Taking the Next Step
Determining whether testosterone therapy is appropriate for you requires individualized evaluation. Laboratory values, symptoms, medical history, and personal goals all factor into the decision. At Ageless Center, we provide comprehensive assessment and ongoing partnership throughout your treatment.
If you are experiencing symptoms that may be related to declining testosterone, such as reduced libido, fatigue, decreased muscle mass, or depressed mood, we encourage you to schedule a consultation. Our medical team will help you understand your current hormone status, discuss whether intervention is warranted, and develop a personalized treatment plan if therapy is appropriate.
With locations in Lexington, Louisville, and London, Kentucky, expert hormone evaluation and treatment are within reach. Learn more about how long after starting HRT you can expect to feel results or how to know if you need a dose adjustment.
Lexington Office 149 Moore Drive Lexington, KY 40503 859-335-1330
Louisville Office 10003 Forest Green Blvd Louisville, KY 40223 502-896-0060
London Office 302 Madison Square London, KY 40741
Email: info@agelesscenter.net
